Evaluate Ovulation and PK of Medroxyprogesterone Acetate Following Dose of TV-46046

- Pregnancy | Contraception
- Completed

Study Title: Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Teva Identifier: TV46046-WH-10075

ClinicalTrials.gov Identifier: NCT02817464

Study Status: Completed

Trial Condition(s): Pregnancy | Contraception

Interventions: Drug: TV-46046 - 400 mg/mL | Drug: TV-46046 - 200 mg/mL | Drug: TV-46046 - 300 mg/mL (if warranted)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female

Age group: Adult

Age Range: 18 Years to 40 Years

Trial Duration: October 7, 2016 - December 3, 2018

Phase: Phase 1

Study Type

Interventional